Want BPC-157 and TB-500 working together on a stubborn injury? See if the Wolverine Stack is right for you.
Patients ask about the Wolverine Stack to support:
Both peptides are investigational, and the combination has not been studied in humans. Dr. Ashley Southern, NMD reviews your history, and labs when medically appropriate, before prescribing anything.
Who we serve: Athletes and active adults with nagging injuries who want a physician-guided plan. Patients come from Boise, Meridian, Eagle, Nampa, Star and across the Treasure Valley. Explore all of our peptide therapy in Boise.
★★★★★ 4.9 from 120+ Google reviews
Physician-Prescribed
Never sold from a website
Made in the USA
Every peptide we prescribe is made in the United States
Meridian Clinic
15 minutes from downtown Boise
The Wolverine peptide is not one substance. It is an informal name for a two-peptide combination of BPC-157 and TB-500, nicknamed after the comic book character who heals quickly. Clinics also call it the “Wolverine stack.”
Great fit for
Not a fit
No. BPC-157 is not an FDA approved drug for any condition. Anyone who tells you otherwise is wrong.
The compounding picture is more complicated, and it moved in 2026. Here is what the FDA’s own records show, with sources.
BPC-157 is not on the Category 2 list. Category 2 is the FDA list of bulk drug substances that may present significant safety risks in compounding. BPC-157 was on that list. It now appears instead in the FDA table of nominations that were withdrawn.
Being withdrawn from Category 2 is not the same as being approved. It means the nomination was pulled. It does not mean the FDA approved the substance for compounding.
The FDA scheduled a further review. Its Pharmacy Compounding Advisory Committee met on July 23 and 24, 2026. BPC-157 was on the agenda for possible addition to the 503A bulks list. The review was tied to an ulcerative colitis indication.
FDA has posted no minutes or voting results. Trade press (AJMC, RAPS) reported that the committee voted 8 to 6, with 1 abstention, to recommend adding BPC-157 to the 503A bulks list. That vote is a non-binding recommendation, and FDA has not proposed adding it.
Where that leaves it today. BPC-157 is not approved. It is not in Category 2. BPC-157 is not currently included in Category 1 of FDA’s 503A interim compounding framework. Its use in humans is investigational, and federal compounding requirements apply.
BPC-157 also appears on the World Anti-Doping Agency prohibited list. If you are a tested athlete, this is not an option. We will tell you so.
FDA regulatory status of BPC-157: primary sources
FDA. Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety Risks. Content current as of April 22, 2026.
FDA. July 23 to 24, 2026 Meeting of the Pharmacy Compounding Advisory Committee.
Federal Register. Pharmacy Compounding Advisory Committee; Notice of Meeting; Request for Comments: Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List. Published April 16, 2026.
Sources
The research on BPC-157 and TB-500
Last reviewed: October 2026
Searching for BPC-157 or the Wolverine stack in Boise? Our clinic is in Meridian, roughly fifteen minutes from downtown Boise. That puts us central to the whole Treasure Valley. We see patients from Eagle, Nampa, Kuna, Star, Middleton and Caldwell.
Alturas Medical Weight Loss
1532 W Cayuse Creek Dr
Meridian, ID 83646
(208) 690-2040
Alturas Medical Weight Loss is a physician-led medical clinic, not a subscription service. Every plan is prescribed and overseen by Dr. Ashley Southern, NMD, begins with a medical evaluation rather than a questionnaire, with lab work whenever it is medically appropriate, and is adjusted to how you actually respond. You can review our wider peptide therapy program for context.
Every protocol at Alturas Medical Weight Loss starts the same way, and none of it happens through a questionnaire.
Start with a free fifteen minute phone consultation. If a recovery protocol is appropriate, we order labs. We review your history and the injury. Dr. Southern prescribes and monitors the plan. She adjusts it based on how you respond. You can read how this fits our wider peptide therapy in Boise and Meridian.
Dr. Ashley Southern, NMD
Physician and co-founder, Alturas Medical Weight Loss in Meridian, Idaho. Board-certified Naturopathic Medical Doctor prescribing and supervising every peptide protocol at the clinic.
Peptides are an area where the gap between a supervised medical protocol and something bought online is enormous. Dr. Southern’s background in regenerative medicine is the reason Alturas offers them at all. It is also why every protocol here starts with a conversation, and lab work whenever it is medically appropriate, rather than a checkout page.
Credentials at a glance
Read more on the Meet Dr. Ashley Southern page, or book a free consultation.
Wolverine Stack is one of several physician-prescribed peptides we offer at our Meridian clinic, near Boise. Every plan starts with a medical evaluation. Explore our full peptide therapy in Boise program or the related therapies below.
A GHRH analog studied for its effects on visceral adipose tissue and body composition.
Bremelanotide, which acts on melanocortin receptors in the brain. The FDA-approved version (Vyleesi) is approved for low sexual desire in premenopausal women; other uses are off-label.
An investigational peptide fragment of thymosin beta-4, studied primarily in laboratory research involving tissue repair and wound healing.
A peptide that has been studied, mostly in animal research, for tendon, ligament and gut-lining repair. Used in certain physician-supervised recovery protocols.
Two peptides studied for their effects on growth hormone signaling, through different pathways. Human data on each is limited, and the combination has not been studied in humans.
A naturally occurring copper peptide studied for collagen production and skin repair. Most human studies used skin creams.
A naturally occurring repair peptide. Human trials have tested it as eye drops and a skin gel.
The questions people actually ask before starting, answered straight.
Wolverine Stack is an informal name for using two peptides together. Those two are BPC-157 and TB-500. The goal is tissue repair and recovery. It is not a brand or a single product. It is not an approved medication.
Two synthetic peptides. BPC-157, derived from a protein found in gastric juice, and TB-500, a fragment of thymosin beta-4. They are paired for their complementary roles in the repair process.
No. The Wolverine Stack is not an FDA-approved therapy, and neither of its two components is an FDA-approved drug.
No. BPC-157 is not FDA approved for any condition. No clinic can honestly claim otherwise. On compounding, the FDA no longer lists it in Category 2. It now sits in the FDA table of withdrawn nominations. It is not currently included in Category 1 of FDA’s 503A interim compounding framework either. An FDA advisory committee reviewed it in July 2026. Trade press reported an 8 to 6 vote to recommend adding it to the 503A bulks list. The vote is non-binding, FDA has posted no official results, and FDA has not acted on it.
No. TB-500 is not an FDA approved drug. Thymosin beta-4 is the protein it derives from. That protein has been tested in human trials as eye drops and a topical wound gel, with mixed results. It is not approved for any use. TB-500 is also not currently listed in the FDA Category 2 bulk substances list.
Alturas Medical Weight Loss is a medical clinic in Meridian, Idaho. We are at 1532 W Cayuse Creek Dr, Meridian, ID 83646. That is about fifteen minutes from downtown Boise, with free on-site parking. We see patients from Boise, Eagle, Nampa, Kuna, Star, Middleton and Caldwell. Call (208) 690-2040 or schedule a consultation.
No. BPC-157 is one of the two peptides in the stack. Used on its own it is simply BPC-157. The Wolverine Stack refers to pairing it with TB-500.
No. TB-500 is the second of the two peptides. The Wolverine Stack is the combination, not either component alone.
Not in the sense of proven human clinical evidence. BPC-157 has a substantial body of animal research. TB-500 has preclinical work behind it. Published human trials are very limited. The pairing itself has never been studied as a combination in humans.
You can contact us through the web form. You can also call or text 208.690.2040. Read more about our peptide therapy program, or schedule a consultation.
Our clinic is in Meridian, Idaho, about fifteen minutes from downtown Boise. There is free on-site parking. The first step is a free fifteen minute phone call. There is no commitment.
For men and women
Recovery, energy and wellness